156 related articles for article (PubMed ID: 7371709)
1. A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol.
Kendall MJ; John VA; Quarterman CP; Welling PG
Eur J Clin Pharmacol; 1980 Feb; 17(2):87-92. PubMed ID: 7371709
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.
Kendall MJ; Jack DB; Woods KL; Laugher SJ; Quarterman CP; John VA
Br J Clin Pharmacol; 1982 Mar; 13(3):393-8. PubMed ID: 7059440
[TBL] [Abstract][Full Text] [Related]
3. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
Grainger SL; John VA; Shotton PA; Smith SE
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
[TBL] [Abstract][Full Text] [Related]
5. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
Folgering H; van Bussel M
Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
Oosterhuis B; Jonkman JH; Kerkhof FA
Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
[TBL] [Abstract][Full Text] [Related]
7. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
Freestone S; Silas JH; Lennard MS; Ramsay LE
Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
[TBL] [Abstract][Full Text] [Related]
11. A multiple dose comparative study of the pharmacodynamic and pharmacokinetic behaviour of polymer-matrix and Oros dosage forms of oxprenolol in healthy volunteers.
Woods KL; Jack DB; Kendall MJ; Halsey A; O'Donnell ML; Warrington SJ; John VA
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):177S-184S. PubMed ID: 4005120
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
13. A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol.
Nievel JG; Harvard CW
Curr Med Res Opin; 1981; 7(8):503-15. PubMed ID: 7030636
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
Quaterman CP; Kendall MJ; Welling PG
Eur J Clin Pharmacol; 1979 Mar; 15(2):97-103. PubMed ID: 436924
[TBL] [Abstract][Full Text] [Related]
16. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
[TBL] [Abstract][Full Text] [Related]
18. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
Rydén L; Kristensson BE; Westergren G
Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
[TBL] [Abstract][Full Text] [Related]
20. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
Mucklow JC; Kuhn S
Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
